Shibin Qu

4.0k total citations · 1 hit paper
22 papers, 2.9k citations indexed

About

Shibin Qu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Shibin Qu has authored 22 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Shibin Qu's work include MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (9 papers) and Cancer-related molecular mechanisms research (9 papers). Shibin Qu is often cited by papers focused on MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (9 papers) and Cancer-related molecular mechanisms research (9 papers). Shibin Qu collaborates with scholars based in China, United States and Denmark. Shibin Qu's co-authors include Haimin Li, Runze Shang, Xisheng Yang, Jianlin Wang, Kefeng Dou, Xiaolei Li, Yuan Gao, Wei Sun, Wenjie Song and Xuan Zhang and has published in prestigious journals such as Gastroenterology, Molecular Cancer and Cancer Letters.

In The Last Decade

Shibin Qu

22 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circular RNA: A new star of noncoding RNAs

2015 1.4k citations Shibin Qu, Xisheng Yang et al. Cancer Letters profile →

Peers

Shibin Qu

MB

CR

IMMUN

ONCOL

BE

Chunyang Bao China

Xisheng Yang China

Linhui Liang China

Mihnea P. Dragomir Germany

Lotte Victoria Winther Stagsted Denmark

Nunu Huang China

Hai Wu China

Sidney W. Fu United States

Masami Ueda Japan

Chunyang Bao China

Shibin Qu

4.2k ×1.7

MB

3.8k ×1.7

CR

100 ×0.7

IMMUN

91 ×0.7

ONCOL

37 ×0.3

BE

Citations per year, relative to Shibin Qu Shibin Qu (= 1×) peers Chunyang Bao

Countries citing papers authored by Shibin Qu

Since Specialization

Citations

This map shows the geographic impact of Shibin Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shibin Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shibin Qu more than expected).

Fields of papers citing papers by Shibin Qu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shibin Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shibin Qu. The network helps show where Shibin Qu may publish in the future.

Co-authorship network of co-authors of Shibin Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Shibin Qu. A scholar is included among the top collaborators of Shibin Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shibin Qu. Shibin Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Zhang, Wenjie, Zhipeng Yang, Jingshi Zhou, et al.. (2024). Circular RNAs in tumor immunity and immunotherapy. Molecular Cancer. 23(1). 171–171. 19 indexed citations

2.

Niu, Kunwei, et al.. (2023). Protective effect of HDACIs in improves survival and organ injury after CLP-induced sepsis. Surgery Open Science. 12. 35–42. 4 indexed citations

3.

Qu, Shibin, Kunwei Niu, Jianlin Wang, et al.. (2020). LINC00671 suppresses cell proliferation and metastasis in pancreatic cancer by inhibiting AKT and ERK signaling pathway. Cancer Gene Therapy. 28(3-4). 221–233. 14 indexed citations

4.

Lin, Zhibin, Shibin Qu, Wei Peng, et al.. (2020). <p>Up-Regulated CCDC34 Contributes to the Proliferation and Metastasis of Hepatocellular Carcinoma</p>. OncoTargets and Therapy. Volume 13. 51–60. 8 indexed citations

5.

Qu, Shibin, Haimin Li, & Zhengcai Liu. (2020). A Rare Cause of Rash. Gastroenterology. 160(6). 1943–1946. 1 indexed citations

6.

Tian, Yuzi, Shibin Qu, Hasan B. Alam, et al.. (2020). Peptidylarginine deiminase 2 has potential as both a biomarker and therapeutic target of sepsis. JCI Insight. 5(20). 48 indexed citations

7.

Shang, Runze, Miao Wang, Bin Dai, et al.. (2020). Long noncoding RNA SLC2A1‐AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway. Molecular Oncology. 14(6). 1381–1396. 73 indexed citations

8.

Zhang, Xuan, Zhao-Xu Yang, Kaishan Tao, et al.. (2019). A review of pig liver xenotransplantation: Current problems and recent progress. Xenotransplantation. 26(3). 30 indexed citations

9.

Qu, Shibin, Zhengcai Liu, Xisheng Yang, et al.. (2017). The emerging functions and roles of circular RNAs in cancer. Cancer Letters. 414. 301–309. 219 indexed citations

10.

Zhang, Xuan, Hua Yang, Shuqiang Yue, et al.. (2017). The mTOR inhibition in concurrence with ERK1/2 activation is involved in excessive autophagy induced by glycyrrhizin in hepatocellular carcinoma. Cancer Medicine. 6(8). 1941–1951. 37 indexed citations

11.

Li, Haimin, Huimin Wang, Zhengcai Liu, et al.. (2016). Circular RNA Expression Profile of Pancreatic Ductal Adenocarcinoma Revealed by Microarray. Cellular Physiology and Biochemistry. 40(6). 1334–1344. 122 indexed citations

12.

Shang, Runze, Shibin Qu, & Desheng Wang. (2016). Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects. World Journal of Gastroenterology. 22(45). 9933–9933. 103 indexed citations

13.

Zhang, Zhuochao, Jianlin Wang, Runze Shang, et al.. (2016). MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis. Oncotarget. 7(10). 11595–11608. 42 indexed citations

14.

Qu, Shibin, Yue Zhong, Runze Shang, et al.. (2016). The emerging landscape of circular RNA in life processes. RNA Biology. 14(8). 992–999. 337 indexed citations

15.

Shang, Runze, Jianlin Wang, Wei Sun, et al.. (2015). RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma. Tumor Biology. 37(4). 5097–5105. 22 indexed citations

16.

Qu, Shibin, Xisheng Yang, Xiaolei Li, et al.. (2015). Circular RNA: A new star of noncoding RNAs. Cancer Letters. 365(2). 141–148. 1419 indexed citations breakdown →

17.

Qu, Shibin, Xisheng Yang, Wenjie Song, et al.. (2015). Downregulation of lncRNA-ATB correlates with clinical progression and unfavorable prognosis in pancreatic cancer. Tumor Biology. 37(3). 3933–3938. 51 indexed citations

18.

Qu, Shibin, Wenjie Song, Xisheng Yang, et al.. (2015). Microarray expression profile of circular RNAs in human pancreatic ductal adenocarcinoma. Genomics Data. 5. 385–387. 85 indexed citations

19.

Yang, Xisheng, Jianlin Wang, Shibin Qu, et al.. (2015). MicroRNA-200a suppresses metastatic potential of side population cells in human hepatocellular carcinoma by decreasing ZEB2. Oncotarget. 6(10). 7918–7929. 34 indexed citations

20.

Wang, Jianlin, Xisheng Yang, Bai Ruan, et al.. (2014). Overexpression of miR-200a suppresses epithelial-mesenchymal transition of liver cancer stem cells. Tumor Biology. 36(4). 2447–2456. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact